Sarah T. Connolly’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-18,537
Closed -$1.28M 88
2023
Q2
$1.28M Sell
18,537
-2,328
-11% -$166K 0.77% 47
2023
Q1
$1.55M Buy
20,865
+2,549
+14% +$214K 0.98% 42
2022
Q4
$1.71M Buy
18,316
+114
+0.6% +$11K 1.16% 30
2022
Q3
$1.74M Sell
18,202
-280
-2% -$27.7K 1.27% 25
2022
Q2
$1.71M Sell
18,482
-1,705
-8% -$166K 1.17% 31
2022
Q1
$2.04M Sell
20,187
-181
-0.9% -$19K 1.2% 35
2021
Q4
$2.1M Buy
20,368
+7,017
+53% +$648K 1.17% 34
2021
Q3
$1.13M Sell
13,351
-5,900
-31% -$494K 0.93% 40
2021
Q2
$1.61M Buy
19,251
+345
+2% +$28.3K 1.31% 28
2021
Q1
$1.42M Sell
18,906
-210
-1% -$15.3K 1.26% 30
2020
Q4
$1.31M Buy
+19,116
New +$1.24M 1.19% 33

Other funds holding CVS

Sarah T. Connolly's CVS Position: Q3 2023 in Review

Sarah T. Connolly sold out of CVS Health (CVS) in Q3 2023, closing a stake of 18,537 shares — an estimated $1.28M sold.

Sarah T. Connolly first reported a position in CVS in Q4 2020 and held it in 11 quarters. The position peaked at $2.1M in Q4 2021. 2,114 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

  • Sarah T. Connolly reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
  • Sarah T. Connolly sold 18,537 CVS Health shares in Q3 2023, an estimated $1.28M.
  • Sarah T. Connolly first reported a position in CVS Health in Q4 2020 and held it in 11 quarters.
  • Sarah T. Connolly's CVS Health position peaked at $2.1M in Q4 2021.
  • 2,114 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on Sarah T. Connolly's 13F filing for Q3 2023, filed 23 Oct 2023.